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Statement of the Problem 
Ventilator associated pneumonia (VAP) is a common complication in 
mechanically ventilated patients. It causes substantial morbidity and 
mortality, as well as substantial cost to the patients and healthcare 
systems. One of the major risk factors identified for risk of VAP is the 
aspiration of secretions from the oropharynx. One intervention aimed 
at decreasing the incidence of secretion aspiration is an endotracheal 
tube (ETT) that can be hooked up to suction, providing continuous 
subglottic suctioning. The purpose of this paper was to explore the 
use of continuous subglottic suctioning and its effects on the 
incidence of ventilator-associated pneumonia. Review of literature 
explored studies including randomized control trials and meta-
analyses that measured the effects of continuous subglottic suction 
on the incidence of VAP as well as length of time on ventilator. This 
information was utilized to determine if there is a statistically 
significant difference in the rates of VAP with continuous subglottic 
suction as compared to traditional oral care measures. The review 
demonstrated that there was a statistically significant decrease in the 
rates of VAP in ventilated patients that receive continuous subglottic 
suctioning. 
VAP is a serious, potentially fatal lung infection that develops in 
ventilated patients. 
Hospitals have implemented many different strategies aimed at 
decreasing the rates of VAP, most have been met with limited success 
(Lahoorpour, Delpisheh, & Afkhamzadeh, 2013). Continuous subglottic 
suction is a relatively new therapy in which patients are intubated with 
a specialized endotracheal tube that has a port that allows suction to 
be administered below the area of the glottis. This therapy has been 
implemented to reduce the amount of oral secretions that migrate down 
the endotracheal tube into the lungs, thus possibly reducing the 
occurrence of pneumonia caused by these secretions. Research 
studies were selected based on the criteria that the researchers 
investigated subglottic suctioning, specifically continuous subglottic 
suctioning compared to traditional endotracheal tubes. 
VAP is a serious nosocomial infection causing significant morbidity 
and mortality. More effective prevention measures need to be 
established to reduce incidence of VAP. 
1. What constitutes a VAP?  
2. What are risk factors for developing VAP in critically ill 
patients?  
3. In ventilated patients in the ICU, does continuous subglottic 
suctioning compared to traditional endotracheal tubes reduce 
the incidence of VAP? 
 
These questions are fundamental to understanding VAP, and 
eventually making informed choices that improve the lives of 
patients. These questions will be explored fully in the subsequent 
sections. 
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Continuous Aspiration of Subglottic Secretions, and it’s 
effect on VAP (CHEST. 1999;116(5)1339-1346. 
In order for continuous subglottic suction catheters to become 
implemented into clinical practice in hospitals, there needs to be 
push from physicians. As continuous subglottic suctioning becomes 
more and more accepted into medical literature along with numerous 
trials showing almost complete consensus that VAP rates can be 
significantly lowered with subglottic suctioning, the path towards 
implementation will become clearer. If there becomes a clear 
consensus on the medical benefit of continuous subglottic suctioning, 
the burden falls on the manufacturers to demonstrate cost-
effectiveness with their product. The reality is that in order for 
continuous subglottic suctioning to be feasible, there needs to be a 
way to assess patients at higher risk for VAP. It would most certainly 
be too expensive to implement an across the board change to 
subglottic suction endotracheal tubes. There are many hospital 
patients that have minimal risk for VAP such as patients intubated for 
OR cases, or patients intubated in the Emergency Department for 
drug overdoses, which typically are extubated in less than 48 hours, 
these patients would not need the more costly continuous subglottic 
catheter. This will need to be a gradual implementation. 
C o n t i n u o u s  S u b g l o t t i c  S u c t i o n  C a t h e t e r 
VAP is defined as a pneumonia that develops 48 hours or longer after 
mechanical ventilation is given by means of an endotracheal tube or 
tracheostomy. VAP results from the invasion of the lower respiratory 
tract and lung parenchyma by microorganisms. Intubation 
compromises the integrity of the oropharynx and trachea and allows 
oral and gastric secretions to enter the lower airways. VAP is a 
substantial cost in health care both in terms of dollars spent on patient 
care, and in mortality and morbidity of ventilated patients. 
Santana et al. 2010 states, “Cannulae combined with supra-cuff 
suction devices enable the suction of subglottic secretions is 
beneficial to critically ill patients because these devices reduce 
VAP incidence and, consequently, hospital costs—with no large-
scale adverse effects.” 
Artigas et al. 1995 found, “We found that the use of continuous 
aspiration of subglottic secretions in intubated patients reduced 
the incidence of ventilator-associated pneumonia by 43.4%.” 
In summary, ventilator associated pneumonia has been shown to be a 
significant problem for intubated patients in the ICU. It has shown to 
increase morbidity and mortality, and most prevention efforts have little 
or no effectiveness. The literature review provided evidence regarding 
the effectiveness of continuous subglottic suctioning in decreasing the 
incidence of VAP in a cost effective way. There is some question as to 
their overall safety, and this is an area of continued research. The 
discussion will answer the question of whether continuous subglottic 
suction has the ability to decrease the incidence of VAP. 
There is a litany of information available on the subject of VAP 
prevention; the articles reviewed here have shown that 
prevention is multifactorial. Continuous subglottic suctioning is 
a very helpful tool that can aide in VAP prevention. As medicine 
progresses, it is vital that we use evidence based medicine to 
change our practices to best serve our patient populations. 
